Harvest Technology Group Secures $3.5 Million via 350 Million Share Placement at AUD $0.01 Each

Details of Harvest Technology's $3.5 Million Equity Raise and Placement

Harvest Technology Group Ltd has applied for ASX quotation of 350 million ordinary fully paid shares issued at AUD $0.01 per share, collectively raising $3.5 million. These shares were issued on 23 July 2026 in Australian dollars, reflecting the currency of consideration. This placement is part of a broader transaction previously disclosed on 27 May 2026 via an Appendix 3B filing, confirming the capital raise was a planned financing step rather than an unexpected announcement.

The company noted that additional securities remain to be issued to finalize the transaction, specifically 120 million lead manager options. Such phased issuance is typical in capital raises where lead managers receive options as part of their remuneration alongside cash fees, aligning their incentives with the company’s long-term equity performance.

Post-Quotation Capital Structure and Shareholder Impact

After the quotation of these 350 million shares, Harvest Technology’s total issued capital on the ASX will be 1,941,576,699 ordinary fully paid shares. The newly issued shares represent roughly 18% of the post-quotation share capital, significantly expanding the company’s equity base to meet its financing needs. However, the company has not disclosed how the $3.5 million proceeds will be allocated.

In addition to the quoted shares, Harvest Technology holds a complex portfolio of unquoted securities. This includes 75 million performance rights subject to performance conditions, and approximately 233.9 million options across nine series with varying exercise prices and expiry dates. These unquoted instruments represent potential future dilution, although details on vesting conditions or conversion likelihood were not provided.

Unquoted Options: Exercise Prices, Expiry Dates, and Dilution Risks

The company’s unquoted options portfolio spans multiple years and strike prices. Notable tranches include 32,647,406 options expiring in 2027 at AUD $0.03, 58,947,247 options expiring April 2027 at AUD $0.03, and 81,588,000 options expiring 20 April 2028 at AUD $0.025. Other options expiring in late 2028 at AUD $0.03 include 1,500,000 in October and 1,000,000 in December. These options pose potential equity dilution depending on share price performance and exercise decisions.

Additionally, the company has issued 5,503,397 convertible notes, a separate unquoted security class with undisclosed conversion terms, representing an additional dilution factor. The announcement lacks details on conversion prices, maturity, or coupon rates for these notes.

Performance Rights and Executive Incentives

Harvest Technology has 75 million performance rights outstanding, typically part of executive and employee equity incentive schemes designed to align interests with long-term company performance. The update does not specify performance hurdles, vesting schedules, or beneficiaries. These rights represent about 3.9% of the fully diluted post-quotation ordinary share capital, highlighting the company’s use of equity-based incentives.

Investors interested in dilution impact and performance conditions should monitor future disclosures or the company’s first annual report post-quotation for more detailed remuneration information.

Share Distribution Details Remain Undisclosed

The company provided a distribution schedule template for the 350 million shares but did not complete it in the update. Consequently, the shareholder composition, including the number of recipients, key investors, or institutional versus retail allocations, remains unknown. This limits transparency on shareholder concentration and strategic investor involvement.

Typically, such schedules are submitted to ASX or disclosed to provide market clarity. The absence of this information may indicate separate submission or the need for further investor communications.

Quotation Application Timing and Prior Transaction Announcement

Harvest Technology applied for quotation on the same day the shares were issued, 23 July 2026, consistent with ASX practices for rapid market listing. The underlying transaction was announced on 27 May 2026 via Appendix 3B, giving investors about two months’ notice.

The transaction classification as a "placement or other type of issue" and the outstanding lead manager options suggest financial advisory services were involved, with lead managers compensated partly through options. The company did not disclose cash fees, total compensation value, or terms for the 120 million lead manager options yet to be issued.

Capital Raise Denominated in Australian Dollars

The $3.5 million capital raise was conducted entirely in Australian dollars at AUD $0.01 per share, indicating a domestic investor focus. This straightforward pricing facilitates accessibility for a broad investor base without fractional share complications.

While the announcement does not disclose the opening share price or subsequent trading performance, the round cent pricing provides a clear valuation reference at issuance.

Issued Capital Growth and Company Development Stage

The issuance of 350 million shares expands Harvest Technology’s ordinary share capital to nearly 1.94 billion shares, reflecting a significant equity base growth. Combined with the extensive unquoted securities, this indicates the company is in an early or growth phase relying on equity financing. The update does not provide operational, revenue, market, or geographic details, limiting insight into the rationale behind the capital raise size and structure.

This announcement focuses solely on securities issuance and capital structure, without strategic or operational commentary. Investors should consult the May 2026 Appendix 3B or related prospectus documents for further context.

Outstanding Lead Manager Options and Transaction Completion

Harvest Technology confirmed 120 million lead manager options remain to be issued to complete the May 2026 transaction. Details such as exercise price, expiry, or vesting conditions for these options were not disclosed, nor was a timeline for issuance provided.

Issuance of these options and their potential ASX quotation will finalize the transaction’s securities issuance. Investors should monitor forthcoming announcements for updates on this contingent capital structure element.

Complex Capital Structure and Dilution Considerations

The company’s capital structure includes multiple classes of securities with varying conversion terms. On a fully diluted basis—assuming all performance rights convert and options exercise—the total share count would substantially exceed the current 1.94 billion shares. The 75 million performance rights and 233.9 million options could cause approximately 15.9% dilution if fully converted or exercised, excluding future capital raises.

The 5,503,397 convertible notes add further dilution uncertainty due to undisclosed conversion terms. Investors should seek detailed information from the company or related capital raise documentation to assess potential dilution impacts thoroughly.